Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/249,554external-prioritypatent/US5506209A/en
Priority claimed from US08/249,555external-prioritypatent/US5538952A/en
Application filed by Abbott LabfiledCriticalAbbott Lab
Priority claimed from NZ283578Aexternal-prioritypatent/NZ283578A/en
Publication of NZ329311ApublicationCriticalpatent/NZ329311A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
b-Casein contained in human milk, a recombinant form of b-casein contained in human milk or hydrolysates thereof is used in the manufacture of a medicament for inhibiting the infection of mammalian cells by RSV (Respiratory Syncytial Virus). b-Casein contained in human milk, a recombinant form of b-casein contained in human milk or hydrolysates thereof is used in the manufacture of a liquid nutritional product or an infant formula also containing at least one protein not contained in human milk for inhibiting the infection of mammalian cells by RSV. b-Casein contained in human milk, a recombinant form of b-casein contained in human milk or hydrolysates thereof is used in the manufacture of a enteral nutritional product also containing at least one protein not contained in human milk for treating and/or preventing respiratory tract infection in a mammal by inhibiting the infection of mammalian cells by RSV.
NZ329311A1994-05-261995-03-27use of beta-casein to inhibit infection in mammalian cells by respiratory syncytial virus
NZ329311A
(en)
Protection of the surgical wound following plastic surgery and nursing care to maintain cleanliness of the regions--protection and preservation of the surgical wound following plastic surgery of cleft lip and palate and microtia
Medicinal preparation based on fetal cell suspension, having immune substituting effect and method of treatment of acquired immune deficiency syndrome (HIV infection) with the use of said preparation.